Shingles is dangerous for a meaningful minority of people who get it. Most healthy adults recover fully within a few weeks, but 1 to 4% of people with shingles end up hospitalized for complications, and the virus can cause lasting nerve pain, vision loss, facial paralysis, and a measurably higher risk of heart attack and stroke. Fewer than 100 people in the U.S. die from shingles each year, so fatal outcomes are rare. The real danger lies in complications that reduce quality of life, sometimes permanently.
Chronic Nerve Pain After Shingles
The most common serious complication is postherpetic neuralgia, or PHN: burning, stabbing pain that lingers in the area where the rash appeared long after the blisters have healed. PHN is defined as pain lasting three or more months after the initial outbreak. About 5% of shingles patients still have it at the three-month mark, and 3% continue to experience severe pain a full year later. In some cases, the pain persists for years or even a lifetime.
Age is the single biggest factor. Among people 50 and older, roughly 13% develop PHN. That number climbs steeply: by age 60, about 60% of shingles patients develop it, and by 70 the figure reaches 75%. The pain can be debilitating enough to interfere with sleep, daily activities, and mental health, especially in older adults who may already be managing other conditions.
Vision Loss From Shingles Near the Eye
When shingles reactivates along the nerve branch that serves the forehead and eye, it can inflame structures throughout the eye, from the cornea to the retina. This happens in roughly 4 to 20% of all shingles cases. Of those, about half develop some form of eye involvement.
The stakes are real. In a large study of 869 patients treated at a single ophthalmology center over a decade, moderate vision loss occurred in about 20% of affected eyes and severe vision loss in nearly 8%. Complete loss of vision in the affected eye occurred in 0.7% of cases. Corneal scarring, which can permanently blur vision, develops in about 10% of patients with eye involvement. Older age and a weakened immune system both increase the odds of a worse outcome. If shingles blisters appear on your forehead, the tip of your nose, or around your eye, that warrants urgent evaluation by an eye specialist.
Facial Paralysis and Other Nerve Damage
In less than 1% of shingles cases, the virus reactivates in a nerve cluster near the ear, causing a condition called Ramsay Hunt syndrome. The hallmark is one-sided facial paralysis (complete in about half of patients), ear pain, and blisters in or around the ear canal. Some people also develop hearing loss, ringing in the ears, vertigo, or difficulty speaking clearly.
Recovery is worse than with Bell’s palsy, which causes similar-looking facial drooping from a different cause. Only about 70% of Ramsay Hunt patients regain normal or near-normal facial movement, compared with over 90% for Bell’s palsy. The presentation can be tricky, too. Some patients develop facial paralysis before any rash appears, and a small number never develop a visible rash at all.
Increased Heart Attack and Stroke Risk
Shingles triggers an inflammatory response that extends beyond the skin. Research presented through the American College of Cardiology found that a shingles episode raised the risk of heart attack by 59% and the risk of stroke by 35%. The combined risk of a major cardiovascular event increased by 41%. These elevated risks were highest during the first year after the shingles outbreak and gradually declined over time.
This doesn’t mean shingles will cause a heart attack, but it does mean the virus places temporary stress on the cardiovascular system. For someone who already has risk factors like high blood pressure, high cholesterol, or diabetes, a shingles episode adds another layer of vulnerability during that window.
Why Immunocompromised People Face Greater Danger
People with weakened immune systems, whether from organ transplants, blood cancers, HIV, or medications that suppress immunity, face higher rates of every shingles complication. The risk of developing chronic nerve pain ranges from 6% to 45% across different immunocompromising conditions, compared with roughly 5% in the general population at three months. Hospitalization rates tell a similar story: 14 to 19% of immunocompromised patients with shingles required hospital care in studied groups, far above the 1 to 4% rate in the general population.
Immunocompromised patients are also more likely to develop disseminated shingles, where the virus spreads beyond a single nerve region and can affect internal organs. Rates of disseminated disease ranged from 0% to 32% across studies of transplant recipients, with the highest rates occurring in patients who received the shortest courses of antiviral prevention after their transplant.
How the Vaccine Changes the Equation
The current shingles vaccine (Shingrix) is over 90% effective at preventing both shingles and postherpetic neuralgia in adults 50 and older with healthy immune systems. In adults aged 50 to 69, it prevented 97% of shingles cases. Effectiveness dips slightly with age but remains strong: 91% in adults 70 and older. Protection against chronic nerve pain specifically was 91% in adults 50 and older and 89% in those 70 and older.
Given that the worst complications of shingles, including chronic pain, vision damage, and cardiovascular stress, disproportionately affect older adults, the vaccine addresses the population most at risk. It requires two doses, spaced two to six months apart, and is recommended for all adults 50 and older regardless of whether they remember having chickenpox.